Sector News

Shell opens first UK hydrogen fuel station

February 27, 2017
Life sciences

Royal Dutch Shell PLC has opened a hydrogen refuelling station at the Cobham service station on the M25.

The site is first fully branded and public hydrogen refuelling site in the UK, said Shell, which plans to open two more this year.

Matthew Tipper, Vice President, Future Fuels at Shell said: “Hydrogen has the potential to become a clean and versatile transport fuel for the future.

“Cobham will provide customers with hydrogen fuel cell electric vehicles the ability to refuel simply and quickly, at one of the largest petrol stations in the UK.”

Shell already has hydrogen fuel sites in California and is part of a consortium that will build a network of up to 400 in Germany.

The new station’s hydrogen electrolyser unit was developed by AIM-listed ITM Power plc and Graham Cooley, its chief executive, said he was delighted to have helped bring the UK’s first forecourt hydrogen fuelling site to life.

“Electrolytic Hydrogen is the cleanest and lowest cost renewable fuel available for fuel cell electric vehicles.

“We look forward to working with Shell to introduce additional hydrogen stations on their forecourts in the UK in the near future.”

Hydrogen fuel cell electric vehicles convert hydrogen into electricity and produce only heat and water when driven with a range of up to 700 km without refuelling.

The Shell station is ITM’s fourth in the UK.

By Philip Whiterow

Source: Proactive Investors

comments closed

Related News

September 25, 2022

Rise of the machines: Novo Nordisk pledges $200M to create first quantum computer for life sciences

Life sciences

Big Pharma has long seen the potential for AI and machine learning to accelerate drug development. But Novo Nordisk is going a step further by channeling $200 million toward the creation of a computer that will outrun anything in existence.

September 25, 2022

Mount Sinai AI uncovers new brain analysis method to predict dementia, Alzheimer’s disease

Life sciences

Current methods for diagnosing Alzheimer’s disease rely on a complex combination of self- and caregiver-reported symptoms, a physical examination and either a PET scan or a spinal tap to look for evidence of amyloid plaque build-ups in the brain. But a new artificial intelligence-based method may make the diagnostic process a much more objective one.

September 25, 2022

New AstraZeneca-backed report finds big money behind diverse owners and entrepreneurs in Europe

Life sciences

There is lots of talk about diversity and inclusion in business, including in pharma and medtech. A new report by the Open Political Economy Network (OPEN), a think tank focusing on migration and diversity, released its “Minority Businesses Matter: Europe” report highlighting the successes and challenges of ethnic minority-owned businesses in Europe.